CD8A and melanoma: At the end of expansion, the majority of expanded cells were tetramer+ CD8+ T cells with a effector/memory (i.e., CCR7−CD45RA−) phenotype (Figure 4B), and capable of mediating efficient killing of HLA-A2+MART-1+ (Mel 624) melanoma cells (Figure 4C).